Topics:
Medical Oncology • Hematology • Pediatric Hematology • Benign Hematology • Hemostasis/Thrombosis
How would you manage OCPs in a patient who develops a VTE while on treatment?
In a patient with a medical or personal indication to induce oligomenorrhea/amenorrhea, how would you manage OCP therapy if a patient develops a VTE during treatment course?
Would you considering continuing estrogen-progestin contraception if anticoagulation is continued? Would you switch to a lower dose estrogen formulation? Would you switch to a progestin-only method (including levonorgestrel-releasing IUD)?
Answer from: at Academic Institution
If a patient has a venous thromboembolic event, while on a combined estrogen-progesterone oral contraceptive, it is reasonable to continue the OCP with the initiation of anticoagulation. A study from 2016 revealed that it was safe to continue hormone therapy with the anticoagulation (Martinelli et a...
Sign in or Register to read more